MUKTA GAUTAM-DHAKAL: Open Payments
NPI 1275034837 · RESTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,697 in 111 payments from 20 companies in 2025. Trend: 2023 $2,372 · 2024 $2,219 · 2025 $2,697
Food & beverage: $2,586Education: $111
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 13 | $311 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $271 |
| Otsuka America Pharmaceutical, Inc. | 11 | $253 |
| Teva Pharmaceuticals USA, Inc. | 6 | $237 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $227 |
| Alkermes, Inc. | 9 | $201 |
| Axsome Therapeutics, Inc. | 9 | $200 |
| ABBVIE INC. | 9 | $166 |
| Janssen Pharmaceuticals, Inc | 1 | $141 |
| Vanda Pharmaceuticals Inc. | 3 | $117 |
Products named: REXULTI, TRINTELLIX, CAPLYTA, ARISTADA, VRAYLAR, SPRAVATO, Auvelity, INGREZZA.
Industry payments across VA — which companies pay providers there.
